Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ergoline-induced retroperitoneal fibrosis].

Lars Munksgaard1, Hanne Madsen, Pia Birgitte R Svolgaard

  • 1Odense Universitetshospital, Medicinsk afdeling C, Reumatologisk Afsnit. lamunk@dadlnet.dk

Ugeskrift for Laeger
|March 4, 2006
PubMed
Summary

A patient experienced symptoms like leg swelling and fatigue, initially suspected as cancer. However, retroperitoneal fibrosis (RF) caused by an ergoline-based drug was identified, leading to recovery after drug withdrawal.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time to Next Treatment Within 24 Months (TTNT24) as a Predictor of Survival in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia: A Population-Based Observational Study.

European journal of haematology·2025
Same author

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

HemaSphere·2025
Same author

Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation.

Annals of hematology·2025
Same author

Extramedullary disease in Waldenström macroglobulinemia: A population-based observational study.

EJHaem·2024
Same author

Prognostic impact of nodal involvement in Waldenström macroglobulinaemia.

British journal of haematology·2024
Same author

Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.

Leukemia & lymphoma·2024

Area of Science:

  • Cardiology
  • Nephrology
  • Oncology

Background:

  • Ergoline-based medications are known to cause retroperitoneal fibrosis (RF).
  • Drug-induced conditions can mimic serious diseases like cancer.

Observation:

  • A 69-year-old male presented with anemia, edema, weight gain, and fatigue.
  • Initial investigations suggested malignancy, but retroperitoneal fibrosis (RF) was suspected.
  • The patient had an eight-year history of ergoline-based drug use.

Findings:

  • Withdrawal of the ergoline-based drug led to significant clinical improvement.
  • Resolution of edema, weight gain, and fatigue was observed.
  • The case highlights the importance of considering drug side effects in differential diagnosis.

Related Experiment Videos

Implications:

  • Physicians should maintain a high index of suspicion for drug-induced RF in patients with unexplained symptoms.
  • Thorough medication review is crucial for diagnosing and managing iatrogenic conditions.
  • Early recognition and discontinuation of causative agents can prevent severe complications and improve patient outcomes.